Abstract
Levels of SP-like immunoreactivity were assessed by enzyme immunoassay in exudates induced in the rat by intrapleural injection of either calcium pyrophosphate (CaPP) or carrageenan. SP-like levels increased during the first hour, up to approximately 2 ng/ml, and remained significantly higher than control values from 1 to 6 h after the induction of pleurisy by CaPP. With carrageenan as the irritant, SP-like levels rose during the first 4 h, up to 3 ng/ml, and remained significantly higher than control values from 4 to 24 h. In terms of the total volume of exudate induced by carrageenan, total amounts increased up to 8 ng/rat at 16 h after the beginning of the reaction. Our data demonstrate a detectable release of SP-like material in these pleural exudates and suggest its involvement in the inflammatory response, either directly, or through other mediators, or simply by acting on nociceptive fibers and inducing vascular changes.
Similar content being viewed by others
References
Pernow, B. 1983. Substance P.Pharmacol. Rev. 35:85–141.
Regoli, D., E. Escher, andJ. Mizrahi. 1984. Substance P—structure-activity studies and the development of antagonists.Pharmacology 28:301–320.
Euler, U. S. von, andJ. H. Gaddum. 1931. An unidentified depressor substance in certain tissue extracts.J. Physiol. (London).72:74–87.
Euler, U. S. von. 1936. Preparation of substance P.Scand. Arch. Physiol. 73:142–144.
Hortnaol, H., E. A. Singer, K. Lenz, G. Kleinberger, andH. Lochs. 1984. Involvement of substance P in the pathogenesis of cardiovascular complications in hepatic failure.In Advances in Hepatic Encephalopathy and Urea Cycle Diseases. G. Kleinberger, P. Ferenci, P. Riederer, and H. Thaler, editors. Karger, Basel. 731–739.
Lembeck, F., R. Gamse, andH. Juan. 1977. Substance P and sensory nerve endings.In Substance P. U.S. von Euler and B. Pernow, editors. Raven Press, New York. 169–181.
Ljungdahl, A., T. Hokfelt, andG. Nilsson. 1978. Distribution of substance P-like immunoreactivity in the central nervous system of the rat.Neuroscience 3:861–976.
Marasco, W. A., H. J. Showell, andE. L. Becker. 1981. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil.Biochem. Biophys. Res. Commun. 99:1065–1072.
Bar-Shavit, Z., R. Goldman, Y. Stabinsky, P. Gottlieb, M. Fridkin, V. I. Teichberg, andS. Blumberg. 1980. Enhancement of phagocytosis—a newly found activity of substance P residing in itsN-terminal tetrapeptide sequence.Biochem. Biophys. Res. Commun. 94:1445–1451.
Hartung, H. P., andK. V. Toyka. 1983. Activation of macrophages by substance P: Induction of oxidative burst and thromboxane release.Eur. J. Pharmacol. 89:301–305.
Payan, D. G., D. R. Brewster, andE. J. Goetzl. 1983. Specific stimulation of human T-lymphocytes by substance P.J. Immunol. 131:1613–1615.
Payan, D. G., D. R. Brewster, A. Missirian-Bastian, andE. J. Goetzl. 1984. Substance P recognition by a subset of human T lymphocytes.J. Clin. Invest. 74:1532–1539.
Lee, C. M., L. L. Iversen, M. R. Hanley, andB. E. B. Sandberg. 1982. The possible existence of multiple receptors for substance P.Arch. Pharmacol. 318:281–287.
Watson, S. P. 1984. Are the proposed substance P receptor sub-types, substance P receptors?Life Sci. 35:797–808.
Jesell, T. M. 1983. Substance P in the nervous system.Hand. Neuropharmacol. 16:1–105.
Nicoll, R. A., C. Schenker, andS. E. Leeman. 1980. Substance P as a transmitter candidate.Annu. Rev. Neurosci. 3:227–268.
Otsuka, M., andS. Konishi. 1976. Substance P and excitatory transmitter of primary sensory neurons.Cold Spring Harbor Symp. Quant. Biol. 40:135–143.
Gamse, R. 1984. Physiologie und Pathophysiologie der Substanz P.Arzneim-Forsch. Drug Res. 34:1074–1079.
Lembeck, F., andP. Holzer. 1979. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation.Arch. Pharmacol. 310:175–183.
Lembeck, F., J. Donnerer, andF. C. Colpaert. 1981. Increase in substance P in primary afferent nerves during chronic pain.Neuropeptides 1:175–181.
Saria, A., R. Gamse, J. M. Lundberg, T. Hokfelt, E. Theodorsson-Norheim, J. Petermann, andJ. A. Fischer. 1985. Co-existence of tachykinins and calcitonin-gene-related peptide in sensory nerves in relation to neurogenic inflammation.In Takykinin Antagonists. R. Hakanson and F. Sundler, editors. Elsevier, Amsterdam. 149–157.
Devillier, P., M. Renoux, J. P. Giroud, andD. Regoli. 1985. Peptides and histamine release from rat peritoneal mast cells.Eur. J. Pharmacol. 117:89–96.
Shibata, H., M. Mio, andK. Tasaka. 1985. Analysis of the mechanism of histamine release induced by substance P.Biochem. Biophys. Acta 846:1–7.
Skofitsch, G., J. M. Savitt, andD. M. Jacobowitz. 1985. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery.Histochemistry 82:5–8.
Levine, J. D., R. Clark, M. Devor, C. Helms, M. A. Moskowitz, andA. I. Basbaum. 1984. Intraneuronal substance P contributes to the severity of experimental arthritis.Science 226:547–549.
Levine, J. D., D. H. Collier, A. I. Basbaum, M. A. Moskowitz, andC. A. Helms. 1985. Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis.J. Rheumatol. 12:406–411.
Iversen, L. L. 1985. The possible role of neuropeptides in the pathophysiology of rheumatoid arthritis.J. Rheumatol. 12:399–400.
Langner, A., H. Schumann, H. Bekemeier, P. Oehme, andR. Rathsack. 1984. Substance P—a potential mediator of inflammation.In Vasal, Humoral and Cellular Aspects of Inflammation and Inhibition of Inflammation. H. Bekemeier and R. Hirschelman, editors. Halle, Saale, GDR. 69–78.
Jackson, B., D. White, R. Cubela, andR. Helme. 1985. Angiotensin converting enzyme and substance P changes in blister fluid following afferent nerve stimulation in the rat.Clin. Exp. Pharmacol. Physiol. 12:187–191.
Devillier, P., B. Weill, M. Renoux, C. Menkes, andP. Pradelles. 1986. Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with inflammatory rheumatic diseases.N. Engl. J. Med. 314:1323.
Jonsson, C. E., E. Brodin, C. J. Dalsgaard, andA. Haegerstrand. 1986. Release of substance-P-like immunoreactivity in dog paw lymph after scalding injury.Acta Physiol. Scand. 126:21–24.
Wallengren, J., R. Ekman, andH. Moller. 1986. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.Acta Dermatol. Venereol., Stock. 66:23–28.
Helme, R. D., G. M. Koschorke, andM. Zimmermann. 1986. Immunoreactive substance P release from skin nerves in the rat by noxious thermal stimulation.Neurosci. Lett. 63:295–299.
Pradelles, P., J. Grassi, andJ. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay.Anal. Chem. 57:1170–1173.
Renzi, D., J. Y. Couraud, Y. Frobert, M. C. Nevers, P. Geppeti, P. Pradelles, andJ. Grassi. 1987. Enzyme immunoassay for substance P using acetylcholinesterase as label.In Trends in Cluster Headaches. F. Sicuteri et al., editors. Elsevier, B.V., Amsterdam. 125–134.
Massoulie, J., andS. Bon. 1976. Affinity chromatography of acetylcholine esterase. The importance of hydrophobic interactions.Eur. J. Biochem. 68:531–539.
Couraud, J. Y., E. Escher, D. Regoli, V. Imhoff.B. Rossignol, andP. Pradelles. 1985. Anti-substance P anti-idiotypic antibodies. Characterization and biological activities.J. Biol. Chem. 260:9461–9469.
Giroud, J. P., D. A.Willoughby, and C. J.Dunn. 1975. Investigation of prostaglandins and other mediators in various inflammatory exudates.In Physiopathologie de l'Articulation. F. Delbarre, editor, INSERM Symposium, Paris.48:63–74.
Tissot, M., C. Bonne, B. Martin, M. Solier, andJ. P. Giroud. 1984. Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.Agents Actions 14:76–81.
Tissot, M., D. Regoli, andJ. P. Giroud. 1985. Bradykinin levels in inflammatory exudates.Inflammation 9:419–424.
Foreman, J., andC. Jordan. 1983. Histamine release and vascular changes induced by neuropeptides.Agents Actions 13:105–116.
Iverfeldt, K., L. L. Peterson, E. Brodin, S. O. Ogren, andT. Bartfai. 1986. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.Arch. Pharmacol. 333:1–6.
Shibata, M., T. Ohkubo, H. Takahashi, andR. Inoki. 1986. Interaction of Bradykinin with substance P on vascular permeability and pain response.Jpn. J. Pharmacol. 41:427–429.
Hartung, H. P., K. Wolters, andK. V. Toyka. 1986. Substance P: Binding properties and studies on cellular responses in guinea pig macrophages.J. Immunol. 136:3856–3863.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tissot, M., Pradelles, P. & Giroud, J.P. Substance-P-like levels in inflammatory exudates. Inflammation 12, 25–35 (1988). https://doi.org/10.1007/BF00915889
Issue Date:
DOI: https://doi.org/10.1007/BF00915889